
---
title: '普利制药：左乙拉西坦注射液获得阿联酋批准'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=9527'
author: 证券时报网
comments: false
date: Thu, 19 May 2022 16:47:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=9527'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ300630" style="color: #2f67d1;text-decoration: none;" code="300630" target="_blank">普利制药</a>(300630)5月19日晚间公告，公司于近日收到阿联酋卫生和预防部签发的左乙拉西坦注射液的批准通知。左乙拉西坦注射液是抗癫痫药物。</p>

                  
</div>
            